Iran is to launch its first nanomedicine, an antibiotic called SinaDoxosome, in March 2012, the Iranian government announced on 11 October.
The government said the medicine would provide an alternative to a US product, Doxorubicin, which has been on the market for 13 years. The medicine is for use in cancer treatments.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.